
Research
Latest News

Latest Videos

More News

Our top cannabis news topics this week: NY OCM executive director resigns, biosolids for hemp fertilizer, Ohio SB 56 approved by Senate, enforcing new hemp legislation, and patterns of CBD use for dogs.

The report breaks down the structural challenges faced by the hemp markets in the region and highlights paths for growth.

The cross-sectional analysis used hair follicle testing to determine THC use in individuals with schizophrenia, then compared MetS prevalence in cannabis consumers and non consumers.

The review analyzed more than 2,500 articles, finding inconsistent evidence for certain conditions and an increased risk for harm.

In a first-of-its-kind US field trial, The University of Illinois Urbana-Champaign, is exploring how hemp biosolids can be utilized as a sustainable fertilizer.

Our top cannabis news topics this week: Texas medical cannabis, first Native American-owned East Coast cannabis brand, pivoting with hemp manufacturing, low-dose CBD and stress, and alcohol-induced liver disease.

The research analyzed data from the Dog Aging Project, finding prevalence of use for certain conditions and behavior changes over time.

In a UK Biobank study on data from adults aged 60 and older, cannabis use was not found to cause widespread cognitive harm, though with mixed results on benefits and risks.

The retrospective observational study examined the effect of cannabis on the risk of alcohol-associated liver disease in patients with alcohol use disorder.

The study compared the effects of a 30-day regimen of CBD oil or a placebo oil on stress in university students, compared to no treatment.

Our top cannabis news topics this week: celebrating Green Wednesday, Ohio’s Senate Bill 56 updates, a message from the US Hemp Roundtable, Healer’s November webinar, and research on terpenes and the ECS.

In honor of Green Wednesday on November 26, 2025, we are excited to share with you our Green Wednesday-themed round up of medical cannabis research.

This month’s webinar explored recently published studies on cannabis for diabetic neuropathy, chronic low back pain, and opioid induced persistent apnea.

Study researchers from Israel recently discovered that cannabis terpenes can activate endocannabinoid receptors.

Our top cannabis news topics this week: cannabis violations prosecutions and new research on cannabis aromas, osmotic stress, smoking and alcohol, and Alzheimer’s.

In November’s Healer webinar, Dustin Sulak, DO, discussed several studies on how cannabinoids affect symptoms of cognitive decline and Alzheimer's disease progression.

A recent study found that smoking cannabis may lead to decreased alcohol consumption.

The Veterans of Foreign Wars in the United States sent an open letter to House and Senate leaders requesting continued cannabinoid research to support veteran treatment alternatives.

The research compared two medical cultivars grown using precision water stress, demonstrating a potential for a genetic tolerance for salinity.

Researchers with Oregon State University analyzed responses from panelists sampling cannabis inflorescence aroma, proposing a common framework for an established vocabulary.

Our top cannabis news topics this week: impacts on the hemp industry from the end of the government shutdown, regulation and business updates from Minnesota, and a Gallup poll on cannabis legalization.

The study compared the risk factors and cannabis use among youth in the years before and after legalization in 2018, identifying a need for adapting prevention efforts.

MoreBetter Ltd, study organizers urge legislators to view the data in their before voting on a Senate hemp bill that could cause harm to the industry by redefining hemp THC amounts.

Co-use of cannabis and alcohol among a sample of college students found positive associations of depression among both male and female students.

Results from one of its annual public opinion surveys indicate that support for cannabis legalization remains high in 2025, but also shows changing perceptions on illegal drugs.












